Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$233M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Nelson Steven Charles | Sep 11, 2024 | Buy | 5,000 | $0.8045 | $4,000 |
| Nelson Steven Charles | Sep 9, 2024 | Buy | 5,000 | $0.8 | $4,000 |
| Raphael Erez | Aug 27, 2024 | Buy | 5,000 | $0.88 | $4,400 |
| Nelson Steven Charles | Aug 23, 2024 | Buy | 5,000 | $0.9499 | $4,700 |
| Raphael Erez | Aug 21, 2024 | Buy | 5,000 | $0.95 | $4,800 |
| Nelson Steven Charles | Aug 20, 2024 | Buy | 5,000 | $0.9369 | $4,700 |
| Raphael Erez | Aug 19, 2024 | Buy | 5,000 | $0.9 | $4,500 |
| Raphael Erez | Aug 16, 2024 | Buy | 3,000 | $0.9 | $2,700 |
| Raphael Erez | Aug 16, 2024 | Buy | 2,000 | $0.89 | $1,800 |
| Matheis Dennis | May 4, 2023 | Buy | 50 | $1000 | $50,000 |
| Shaked Yoav | May 4, 2023 | Buy | 40 | $1000 | $40,000 |
| KAPLAN JON H. | May 4, 2023 | Buy | 30 | $1000 | $30,000 |
| Raphael Erez | May 4, 2023 | Buy | 30 | $1000 | $30,000 |
| Raphael Erez | Jan 13, 2023 | Sell | 1,200 | $6.2075 | $7,400 |
What's the latest insider transaction for DarioHealth?
The most recent insider transaction for DarioHealth was conducted by Nelson Steven Charles, who sold 5,000 shares on September 11, 2024 at a price of $0.80 per share.
Which insider bought the most DRIO stock over the last two years?
Matheis Dennis has bought the most DRIO stock in the last 2 years, with a total value of $50,000.
Which insider has sold the most DRIO stock over the last two years?
Raphael Erez has sold the most DRIO stock in the last 2 years, with a total value of $7,400.
What is the total value of insider transactions for DarioHealth (DRIO) in the last 2 years?
According to our estimates, the total value of insider transactions for DarioHealth in the last 2 years is positive, amounting to $180,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
How do insider transactions over the last 2 years reflect on DarioHealth's market confidence?
Over the last 2 years, insider transactions for DarioHealth have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
